Trials / Completed
CompletedNCT02214056
Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility
Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Part I Feasibility
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to assess the feasibility of standardized screening for comorbidities among patients with one or more of three chronic diseases (diabetes, COPD, atherosclerosis) by a mobile unit at times and localities under-served by health actors.
Detailed description
The investigators secondary objectives include assessing patient and GP satisfaction in relation to the mobile screening team.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patient recruitment | Participating general practitioners (GPs) will inform and recruit participants from among regular patient consults. Using the provided web tools, GPs will organize a visit with the mobile team that fits the needs of the patient. |
| PROCEDURE | Mobile team exam | Each patient enrolled will receive a standardized assessment in one locality, made in about two hours, and comprising: questionnaire responses, a complete physical exam, a 12-lead ECG, spirometry before and after administration of β2-agonists, an arterial Doppler ultrasound (carotid and abdominal), ankle-brachial index (systolic pressure at the toe). At the end of two hours, each patient will evaluate their satisfaction using a survey of acceptability and leave with a full report to the attention of their general practitioner (copy sent to Physician if needed) detailing the results of the different examinations. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-08-12
- Last updated
- 2015-05-06
Locations
13 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02214056. Inclusion in this directory is not an endorsement.